These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27376089)

  • 1. The Role of Hyperglycemia and Insulin Resistance in the Development and Progression of Pulmonary Arterial Hypertension.
    Grinnan D; Farr G; Fox A; Sweeney L
    J Diabetes Res; 2016; 2016():2481659. PubMed ID: 27376089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial Hypertension.
    Whitaker ME; Nair V; Sinari S; Dherange PA; Natarajan B; Trutter L; Brittain EL; Hemnes AR; Austin ED; Patel K; Black SM; Garcia JGN; Yuan Md PhD JX; Vanderpool RR; Rischard F; Makino A; Bedrick EJ; Desai AA
    Am J Med; 2018 Jun; 131(6):702.e7-702.e13. PubMed ID: 29421689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Critical Role of Pulmonary Arterial Compliance in Pulmonary Hypertension.
    Thenappan T; Prins KW; Pritzker MR; Scandurra J; Volmers K; Weir EK
    Ann Am Thorac Soc; 2016 Feb; 13(2):276-84. PubMed ID: 26848601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of Metabolic Memory in the Development of Vascular Complications in Diabetic Patients.
    Luna P; Guarner V; Farías JM; Hernández-Pacheco G; Martínez M
    J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1369-78. PubMed ID: 27256447
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
    Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
    Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-223-IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach.
    Shi L; Kojonazarov B; Elgheznawy A; Popp R; Dahal BK; Böhm M; Pullamsetti SS; Ghofrani HA; Gödecke A; Jungmann A; Katus HA; Müller OJ; Schermuly RT; Fisslthaler B; Seeger W; Fleming I
    Cardiovasc Res; 2016 Aug; 111(3):184-93. PubMed ID: 27013635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-nitroso human serum albumin attenuates pulmonary hypertension, improves right ventricular-arterial coupling, and reduces oxidative stress in a chronic right ventricle volume overload model.
    Rungatscher A; Hallström S; Linardi D; Milani E; Gasser H; Podesser BK; Scarabelli TM; Luciani GB; Faggian G
    J Heart Lung Transplant; 2015 Mar; 34(3):479-88. PubMed ID: 25511748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pressure-overloaded right ventricle in pulmonary hypertension.
    Bristow MR; Zisman LS; Lowes BD; Abraham WT; Badesch DB; Groves BM; Voelkel NF; Lynch DM; Quaife RA
    Chest; 1998 Jul; 114(1 Suppl):101S-106S. PubMed ID: 9676654
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes Enters Stage Right: Genetic Association Studies Suggest Diabetes Promotes Pulmonary Hypertension and Right Ventricular Dysfunction.
    Kazmirczak F; Prins KW
    J Am Heart Assoc; 2023 Aug; 12(15):e030954. PubMed ID: 37522171
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary arterial hypertension: Basic knowledge for clinicians.
    Santos-Ribeiro D; Mendes-Ferreira P; Maia-Rocha C; Adão R; Leite-Moreira AF; Brás-Silva C
    Arch Cardiovasc Dis; 2016 Oct; 109(10):550-561. PubMed ID: 27595464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary hypertension and right ventricular failure. Part II. Patients with left ventricular involvement].
    Batyraliev TA; Makhmutkhodzhaev SA; Soplevenko AV; Pershukov IV; Sidorenko BA; Preobrazhenskiĭ DV
    Kardiologiia; 2006; 46(3):79-84. PubMed ID: 16710265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.
    Bruce E; Shenoy V; Rathinasabapathy A; Espejo A; Horowitz A; Oswalt A; Francis J; Nair A; Unger T; Raizada MK; Steckelings UM; Sumners C; Katovich MJ
    Br J Pharmacol; 2015 May; 172(9):2219-31. PubMed ID: 25522140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and metabolic recovery of the right ventricle during Bosentan therapy in idiopathic pulmonary arterial hypertension.
    Spindler M; Schmidt M; Geier O; Sandstede J; Hahn D; Ertl G; Beer M
    J Cardiovasc Magn Reson; 2005; 7(5):853-4. PubMed ID: 16353449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary vascular function in insulin resistance and diabetes.
    Moral-Sanz J; Moreno L; Cogolludo A; Perez-Vizcaino F
    Curr Vasc Pharmacol; 2014 May; 12(3):473-82. PubMed ID: 24846236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus and diabetes-associated vascular disease.
    Kirpichnikov D; Sowers JR
    Trends Endocrinol Metab; 2001 Jul; 12(5):225-30. PubMed ID: 11397648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary vascular collagen content, not cross-linking, contributes to right ventricular pulsatile afterload and overload in early pulmonary hypertension.
    Wang Z; Schreier DA; Abid H; Hacker TA; Chesler NC
    J Appl Physiol (1985); 2017 Feb; 122(2):253-263. PubMed ID: 27856711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal denervation in cardiometabolic disease: concepts, achievements and perspectives.
    Grassi G
    Nutr Metab Cardiovasc Dis; 2013 Feb; 23(2):77-83. PubMed ID: 23149073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of insulin resistance on ventricular function in pulmonary arterial hypertension.
    Brunner NW; Skhiri M; Fortenko O; Hsi A; Haddad F; Khazeni N; Zamanian RT
    J Heart Lung Transplant; 2014 Jul; 33(7):721-6. PubMed ID: 24819985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Profiling of Right Ventricular-Pulmonary Vascular Function Reveals Circulating Biomarkers of Pulmonary Hypertension.
    Lewis GD; Ngo D; Hemnes AR; Farrell L; Domos C; Pappagianopoulos PP; Dhakal BP; Souza A; Shi X; Pugh ME; Beloiartsev A; Sinha S; Clish CB; Gerszten RE
    J Am Coll Cardiol; 2016 Jan; 67(2):174-189. PubMed ID: 26791065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.